Natixis Advisors LLC increased its stake in Snap-On Incorporated (NYSE:SNA) by 5.8% in the fourth quarter, acquiring an additional 6,034 shares to bring its total to 109,391 shares valued at approximately $37.7 million. Despite missing EPS estimates slightly, Snap-On reported stronger-than-expected revenue of $1.21 billion, a 5.8% increase year-over-year. The company maintains a "Moderate Buy" consensus rating from analysts with an average target price of $387.67, alongside recent insider selling and a newly authorized $500 million stock repurchase plan.

Kesler Norman & Wride LLC has initiated a new position in VeriSign, Inc. (NASDAQ:VRSN) by acquiring 4,267 shares valued at approximately $1.04 million during the fourth quarter. This move comes as institutional investors and hedge funds own a significant 92.9% of VeriSign's stock. The company recently exceeded earnings estimates with an EPS of $2.34 and reported a 6.6% year-over-year revenue increase, while analysts maintain a "Moderate Buy" rating with an average price target of $317.67.

Natixis Advisors LLC has disclosed a $37.58 million stake in Xylem Inc., despite reducing its holdings by 26.9% in the fourth quarter. Xylem reported stronger-than-expected quarterly earnings and revenue, raised its FY2026 EPS guidance, and announced a quarterly dividend and a $1.5 billion share buyback program. Institutional investors collectively own 87.96% of Xylem's stock, with several other major funds also adjusting their positions.

Natixis Advisors LLC reduced its stake in AutoZone (NYSE:AZO) by 21.5% in the fourth quarter, selling 2,978 shares and retaining 10,884 shares valued at approximately $36.9 million. This adjustment comes as AutoZone reported strong quarterly earnings of $38.07 per share, exceeding analyst estimates, with an 8.4% increase in revenue year-over-year. Despite some recent price target adjustments by analysts, the stock maintains a "Moderate Buy" consensus rating with an average target price of $4,040.87.

Natixis Advisors LLC significantly reduced its stake in Microchip Technology (NASDAQ:MCHP) by 52.1% in Q4, selling over 640,000 shares. This comes as Microchip Technology reported strong quarterly earnings, beating estimates with $0.57 EPS and $1.31 billion in revenue, prompting a "Moderate Buy" rating from analysts and several price target increases. The company also announced a quarterly dividend and expects continued growth, particularly in its data center unit driven by AI infrastructure demand.

Kesler Norman & Wride LLC initiated a new position in Monster Beverage Corporation (NASDAQ:MNST) during the fourth quarter, acquiring 12,167 shares worth approximately $933,000. This move follows strong quarterly results from Monster Beverage, which exceeded revenue and EPS estimates, and a board-approved $500 million share buyback program. Analysts generally maintain a "Moderate Buy" rating for the company, with an average target price of $89.05.

Gaming industry veteran Patrick Ramsey has been appointed to the board of directors of Voyager TopCo, the parent company of IGT and Everi. Ramsey's extensive experience in gaming operations, technology, and business transformation is expected to strengthen the company's global presence. His appointment is pending regulatory approvals and follows his previous leadership roles at Multimedia Games and Caesars Entertainment, and over a decade with Aristocrat Leisure.

Etu Energias is exercising its pre-emption right regarding Chevron's agreement to sell its stakes in two producing oil and gas licenses offshore Angola to Energean. While the transaction between Chevron and Energean remains in effect, Etu's intervention means any assignment to Etu must be on the same terms, including a critical condition requiring the buyer to prove itself a deepwater operator. This development introduces competition for Energean's planned acquisition, which was valued at an initial base payment of $260 million.

International Paper is investing $225 million in a new sustainable packaging plant in Rankin County, Mississippi, to enhance its North American manufacturing network and meet growing demand for fiber-based packaging. The facility, expected to begin commercial operations in late 2027, will feature advanced automation and safety technologies to improve efficiency and support the company's long-term growth strategy. This investment is a significant step to modernize International Paper's production network and strengthen its position in the competitive packaging market.

Regeneron Pharmaceuticals and CytomX have expanded their research and licensing partnership to develop conditionally activated bispecific antibody cancer therapies, increasing the total potential value of the deal to $4 billion. This collaboration leverages CytomX’s Probody technology and Regeneron’s Veloci‑Bi bispecific platform to target hard-to-treat tumour types, aiming to improve the safety and effectiveness of T‑cell engager treatments. CytomX will receive a $37 million target nomination payment for two new targets, with Regeneron having options for six more, along with royalties and future milestone payments.